Mode
Text Size
Log in / Sign up
Phase 4 N=183 Randomized Triple-blind Treatment

IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy

Pain

Enrolled (actual)
183
Serious AEs
0.5%
Results posted
Dec 2017
Primary outcome: Primary: Postoperative Pain — 3.55; 3.11 units on a visual analog scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
IV acetaminophen (Drug); placebo (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
University of Pittsburgh
Primary completion
Sep 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Postoperative Pain
3.55; 3.11
SECONDARY
Narcotic Medication Use
16.4; 18.4

Summary

The objective of this study is to quantify the change in post-operative pain scores and narcotic requirements in women receiving pre and post-operative IV acetaminophen compared to placebo in women undergoing laparoscopic hysterectomy.

Eligibility Criteria

Inclusion Criteria

  • Women aged 18-75
  • Ability to read and write in English (our post-operative pain log is only available in English)
  • Planning a laparoscopic hysterectomy (includes total laparoscopic hysterectomy, laparoscopic supracervical hysterectomy, laparoscopically assisted vaginal hysterectomy, with or without salpingooophorectomy)

Exclusion Criteria

  • Answering yes to any of the following questions: "Do you have a history of liver disease, kidney disease, hepatitis C, history of liver failure, greater than 3 drinks per day or being have you ever been told by your doctor that they should not take acetaminophen"
  • History of cardiac arrhythmia
  • History of jaundice
  • Acute abdominal inflammatory or infectious process at time of surgery
  • Known malignancy at time of surgery
  • Known pregnancy at time of surgery
  • Plan to perform additional significant surgical procedure at the time of hysterectomy such as extensive excision of endometriosis on bowel or bladder or pelvic reconstructive procedure
  • >6cm abdominal incision in order to remove the uterus at time of study-related hysterectomy
  • Regular use of narcotic pain medication (defined as use on most days of the week at any point in the past 3 months)
  • Allergy to acetaminophen
  • Women who weigh less than 50 kilograms on the day of surgery.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02400580). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search